News

Dorchester Minerals, L.P. Announces Fourth Quarter Results

Dorchester Minerals, L.P. Announces Fourth Quarter Results

Dorchester Minerals, L.P. Celebrates Strong Fourth Quarter Performance

Dorchester Minerals, L.P. (NASDAQ: DMLP) has made headlines with its announcement regarding the fourth quarter distribution for the year. This valuable cash distribution amounts to $0.739412 per common unit, reflecting robust activity during the three-month period that concluded on December 31, 2024. The payment is scheduled for February 13, 2025, benefiting common unitholders who were on record as of February 3, 2025.

Cash Receipts Breakdown: Royalty Properties

The financial health of Dorchester Minerals is evident in its cash receipts from Royalty Properties, which reached approximately $34.9 million during the fourth quarter. Notably, around 68% of this amount is attributed to oil sales conducted between September and November 2024, along with natural gas sales from August to October 2024. Additionally, approximately 32% of these receipts were derived from previous sales periods.

Net Profits Interest Contributions

Furthermore, cash receipts from the Partnership's Net Profits Interest totaled around $5.4 million for the same period. A significant 61% of these receipts can be traced back to oil and natural gas sales reported from August through October 2024, while 39% resulted from prior periods, showcasing the continued stability and reliability of Dorchester Minerals' operations.

Lease Bonus and Additional Income

In addition to the primary sources of revenue, Dorchester Minerals reported cash receipts of approximately $0.7 million from lease bonuses and other income streams during the fourth quarter. This diversification fondly demonstrates the Company's ability to maximize its potential revenue sources amidst varied market conditions.

A Bite Into Dorchester's Operations

As a leader nestled in Dallas, Dorchester Minerals, L.P. holds a varied portfolio of oil and natural gas interests across 28 states, encompassing both producing and non-producing assets. Those interested in investing can find its common units actively traded on the Nasdaq Global Select Market under the ticker symbol DMLP.

Insights on Non-U.S. Investor Relations

This announcement serves as an important notice for nominees and brokers regarding the distribution to non-U.S. investors. While a part of Dorchester's income may not be effectively connected to the U.S., it is crucial for nominees to regard 100% of the distributions as attributable to effectively connected income with a U.S. trade or business. Non-U.S. investors should be aware of the federal income tax withholding implications that apply.

Looking Forward

As the landscape for oil and gas continues to evolve, Dorchester Minerals remains poised to adapt and thrive amidst uncertainties. The Company understands the significance of fluctuating prices and potential regulatory changes that could impact operations and cash flows moving forward. The ongoing commitment to monitoring economic shifts ensures that Dorchester Minerals stays ahead and maintains its strategic advantage in the industry.

Frequently Asked Questions

What is Dorchester Minerals, L.P.'s cash distribution for Q4 2024?

The cash distribution is $0.739412 per common unit for the fourth quarter of 2024.

When will the distribution be paid?

The distribution will be paid on February 13, 2025, to common unitholders of record as of February 3, 2025.

What were the cash receipts from Royalty Properties in Q4 2024?

The cash receipts from Royalty Properties totaled approximately $34.9 million during the fourth quarter.

How much did Dorchester report from Net Profits Interest?

Dorchester Minerals reported approximately $5.4 million from Net Profits Interest in the same period.

Which markets does Dorchester operate in?

Dorchester Minerals operates in 28 states, managing both producing and non-producing oil and natural gas assets.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 35

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 51

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 119

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 291

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 595

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 321

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 0

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading

Top 5 Most Recently Viewed Articles

Market Reactions: Middle East Tensions and the Vance-Walz Debate

Updated Category News Views 71

Market Reactions to Middle East Tensions US stock futures are experiencing a downward trend as investors react to the escalating violence in the Middle East. With Iran claiming to have ceased its air bombardments on Israel, uncertainty still looms, as Israeli officials pledge a counterattack. This ongoing conflict has already impacted Wall Street, where equity values...

Continue Reading
Class Action Alert for Visa Inc. Shareholders Facing Losses

Updated Category News Views 91

Class Action Notification for Visa Inc. Shareholders The Gross Law Firm is reaching out to shareholders of Visa Inc. (NYSE: V) regarding an important class action that may affect them. If you purchased shares during a specific class period and have suffered losses, your participation could be significant in holding the company accountable. Understanding the Class Period...

Continue Reading
Coca-Cola's Earnings Report: Anticipated Insights and Analysis

Updated Category News Views 205

Coca-Cola's Earnings Report Overview The Coca-Cola Company (NYSE: KO) is on the cusp of unveiling its second-quarter financial results. Investors, analysts, and fans alike are closely watching what insights the beverage giant will provide during this crucial report. With notable figures in the U.S. market keeping an eye on Coca-Cola, the anticipation is palpable. Earnings...

Continue Reading
Maggiano's Unveils Gourmet Italian-American Classics Menu

Updated Category News Views 410

Introduction of Italian-American Classics at Maggiano's Maggiano's Little Italy is embracing the culinary heritage of Italian-American cuisine by introducing a new menu that reflects a dedication to high-quality ingredients and gourmet recipes. Under the expert guidance of award-winning Chef Anthony Amoroso, the restaurant's latest offerings promise to impress food...

Continue Reading
Recognizing Excellence: Pierce & O'Neill Founders Honored

Updated Category News Views 362

Pierce & O’Neill Founders Honored Among Top Attorneys Pierce & O’Neill, LLP, a renowned litigation boutique, is celebrating its founders, Jesse Pierce and Jack O’Neill, for their remarkable achievements in the legal field. Recently recognized in Lawdragon’s prestigious list of the 500 Leading Lawyers in America for 2025, this accolade showcases their exceptional...

Continue Reading